Magnetic resonance enterography to predict subsequent disabling Crohn’s disease in newly diagnosed patients (METRIC-EF)—multivariable prediction model, multicentre diagnostic inception cohort - Summary - MDSpire

Magnetic resonance enterography to predict subsequent disabling Crohn’s disease in newly diagnosed patients (METRIC-EF)—multivariable prediction model, multicentre diagnostic inception cohort

  • By

  • Stuart A. Taylor

  • Shankar Kumar

  • Thomas Parry

  • Sue Mallett

  • Simon Travis

  • Tim Raine

  • Caroline Clarke

  • Jing Yi Weng

  • Gauraang Bhatnagar

  • Stuart Bloom

  • Peter John Hamlin

  • Ailsa Hart

  • Roser Vega

  • Maira Hameed

  • Anisha Bhagwanani

  • Rebecca Greenhalgh

  • Emma Helbren

  • James Stephenson

  • Ian Zealley

  • Vivienne Eze

  • Jamie Franklin

  • Alison Corr

  • Arun Gupta

  • Damian Tolan

  • William Hogg

  • Antony Higginson

  • Mohamed Ahmed

  • Louise Lee

  • Richard Pollok

  • Jaymin Patel

  • Samantha Baillie

  • Steve Halligan

  • Andrew Plumb

  • May 14, 2025

  • 0 min

Share

Objective:

To evaluate whether MRE features at diagnosis can improve the prediction of disabling Crohn’s disease within 5 years in newly diagnosed patients, specifically focusing on the time frame for prediction.

Key Findings:
  • MRE can quantify bowel damage and inflammatory activity, potentially aiding in prognostication.
  • Disabling disease was defined based on specific clinical events occurring more than 90 days after diagnosis, including [insert detailed criteria].
  • The study aimed to identify predictors of disabling disease using MRE features.
Interpretation:

The findings suggest that MRE may serve as a valuable tool for predicting the progression to disabling Crohn’s disease, allowing for targeted early treatment that could significantly improve patient outcomes.

Limitations:
  • The study was non-randomised and single-arm, which may limit generalizability and introduce potential biases.
  • MRE's prognostic utility has not been extensively validated in newly diagnosed patients.
Conclusion:

The METRIC-EF trial aims to establish a predictive model for disabling Crohn’s disease using MRE, which could enhance treatment strategies and ultimately improve patient outcomes.

Original Source(s)

Related Content